Paul Choi Score: 34
Analyst at
Goldman Sachs
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+8.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
44%
7 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
62%
8 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
23%
3 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
55%
6 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
47%
7 W / 8 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 02, 2026 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
BUY |
$90.00
Est. +180%
|
$32.14 | $37.29 |
Pending
|
$34.24
+6.5%
|
| May 07, 2026 |
Lantheus Holdings Inc
LNTH
|
BUY |
$94.00
Est. +3%
|
$91.00 | $104.99 |
Target Met
|
$104.67
+15.0%
|
| Mar 02, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$255.00
Est. +9%
|
$233.50 | $250.74 |
Precision Hit (±3%)
|
$223.29
-4.4%
|
| Oct 30, 2025 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$100.00
Est. +50%
|
$66.62 | $84.94 |
Pending
|
$68.00
+2.1%
|
| Jun 13, 2025 |
UroGen Pharma Ltd
URGN
|
BUY |
$16.00
Est. +33%
|
$12.03 | $32.37 |
Target Met
|
$30.87
+156.6%
|
| Dec 18, 2024 |
Lantheus Holdings Inc
LNTH
|
BUY |
$143.00
Est. +57%
|
$91.15 | $111.29 |
Miss
|
$104.67
+14.8%
|
| Sep 16, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$200.00
Est. +41%
|
$142.26 | $208.16 |
Target Met
|
$223.29
+57.0%
|
| Sep 03, 2024 |
Cytokinetics Inc
CYTK
|
BUY |
$60.00
Est. +10%
|
$54.56 | $59.39 |
Precision Hit (±3%)
|
$71.38
+30.8%
|
| Aug 08, 2024 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$12.00
Est. +2%
|
$11.75 | $19.71 |
Target Met
|
$10.71
-8.9%
|
| Jun 14, 2024 |
UroGen Pharma Ltd
URGN
|
BUY |
$22.00
Est. +26%
|
$17.50 | $18.15 |
Miss
|
$30.87
+76.4%
|
| Jun 07, 2024 |
Regenxbio Inc
RGNX
|
BUY |
$38.00
Est. +176%
|
$13.76 | $15.36 |
Miss
|
$7.07
-48.6%
|
| May 30, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$50.00
Est. +81%
|
$27.61 | $39.54 |
Miss
|
$68.00
+146.3%
|
| May 20, 2024 |
PTC Therapeutics Inc
PTCT
|
SELL |
$32.00
Est. +20%
|
$40.12 | $29.02 (Low) |
Target Met
|
$76.77
-91.4%
|
| May 14, 2024 |
Dynavax Technologies Corp.
DVAX
|
BUY |
$20.00
Est. +82%
|
$11.00 | $14.63 |
Miss
|
$15.50
+40.9%
|
| Feb 21, 2023 |
Vir Biotechnology Inc
VIR
|
BUY |
$28.38
Est. +10%
|
$25.74 | - | - |
$8.61
-66.6%
|
| Feb 16, 2022 |
Global Blood Therapeutics Inc.
GBT
|
BUY |
$69.00
Est. +100%
|
$34.44 | $68.49 |
Bullseye Hit (±1%)
|
$68.49
+98.9%
|
Signal & Target
BUY
$90.00
Start Price
$32.14
Best Price (1Y)
$37.29
Current Price
$34.24
Return
+6.5%
Lantheus Holdings Inc
LNTH
May 07, 2026
Signal & Target
BUY
$94.00
Start Price
$91.00
Best Price (1Y)
$104.99
Current Price
$104.67
Return
+15.0%
Ascendis Pharma A/S - ADR
ASND
Mar 02, 2026
Signal & Target
BUY
$255.00
Start Price
$233.50
Best Price (1Y)
$250.74
Current Price
$223.29
Return
-4.4%
BridgeBio Pharma Inc
BBIO
Oct 30, 2025
Signal & Target
BUY
$100.00
Start Price
$66.62
Best Price (1Y)
$84.94
Current Price
$68.00
Return
+2.1%
UroGen Pharma Ltd
URGN
Jun 13, 2025
Signal & Target
BUY
$16.00
Start Price
$12.03
Best Price (1Y)
$32.37
Current Price
$30.87
Return
+156.6%
Lantheus Holdings Inc
LNTH
Dec 18, 2024
Signal & Target
BUY
$143.00
Start Price
$91.15
Best Price (1Y)
$111.29
Current Price
$104.67
Return
+14.8%
Ascendis Pharma A/S - ADR
ASND
Sep 16, 2024
Signal & Target
BUY
$200.00
Start Price
$142.26
Best Price (1Y)
$208.16
Current Price
$223.29
Return
+57.0%
Cytokinetics Inc
CYTK
Sep 03, 2024
Signal & Target
BUY
$60.00
Start Price
$54.56
Best Price (1Y)
$59.39
Current Price
$71.38
Return
+30.8%
Phathom Pharmaceuticals Inc
PHAT
Aug 08, 2024
Signal & Target
BUY
$12.00
Start Price
$11.75
Best Price (1Y)
$19.71
Current Price
$10.71
Return
-8.9%
UroGen Pharma Ltd
URGN
Jun 14, 2024
Signal & Target
BUY
$22.00
Start Price
$17.50
Best Price (1Y)
$18.15
Current Price
$30.87
Return
+76.4%
Regenxbio Inc
RGNX
Jun 07, 2024
Signal & Target
BUY
$38.00
Start Price
$13.76
Best Price (1Y)
$15.36
Current Price
$7.07
Return
-48.6%
BridgeBio Pharma Inc
BBIO
May 30, 2024
Signal & Target
BUY
$50.00
Start Price
$27.61
Best Price (1Y)
$39.54
Current Price
$68.00
Return
+146.3%
PTC Therapeutics Inc
PTCT
May 20, 2024
Signal & Target
SELL
$32.00
Start Price
$40.12
Best Price (1Y)
$29.02
Current Price
$76.77
Return
-91.4%
Dynavax Technologies Corp.
DVAX
May 14, 2024
Signal & Target
BUY
$20.00
Start Price
$11.00
Best Price (1Y)
$14.63
Current Price
$15.50
Return
+40.9%
Vir Biotechnology Inc
VIR
Feb 21, 2023
Signal & Target
BUY
$28.38
Start Price
$25.74
Best Price (1Y)
-
Current Price
$8.61
Return
-66.6%
Global Blood Therapeutics Inc.
GBT
Feb 16, 2022
Signal & Target
BUY
$69.00
Start Price
$34.44
Best Price (1Y)
$68.49
Current Price
$68.49
Return
+98.9%